Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-07-28
1993-09-14
Hill, Jr., Robert J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530399, 514 21, 514806, A61K 3702, A61K 3736, C07K 710
Patent
active
052448827
ABSTRACT:
An analog of porcine growth hormone, is disclosed which retains the diabetogenic, insulin-sparing and lipolytic properties of porcine growth hormone while being capable of improving growth in mammals.
REFERENCES:
patent: 4670249 (1987-06-01), Ivy et al.
patent: 4699897 (1987-10-01), Jones et al.
patent: 4765980 (1988-08-01), DePrince et al.
patent: 4792546 (1988-12-01), Baker
patent: 4861868 (1989-08-01), Krivi
patent: 5037806 (1991-08-01), Krivi
patent: 5134120 (1992-07-01), Boyd et al.
Seeburg, P. et al., DNA, 2(1):37-45, 1983.
Lewis, U. et al., Biochem. Biophys. Res. Comm., 92(2):511-516, 1980.
R. D. Boyd, et al., J. Animal Sci. 66 (Supp 1), 1988 (Abst).
Allen Marianne Porta
Amgen Inc.
Hill Jr. Robert J.
Jervis Herbert H.
Lentz Edward T.
LandOfFree
Porcine growth hormone analogs, and compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Porcine growth hormone analogs, and compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Porcine growth hormone analogs, and compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2026611